Assess whether intel indicators are prioritized for this network (efa6ca)

Situation

Clinical-trial site anomaly report arrived with an OCC request for model validation of a fair-lending control for OFAC sanctions investigator. That is a US Federal Cybersecurity Threat Intel decision on intel indicators are prioritized in an exporter with a possible OFAC touchpoint.

Decision

OFAC sanctions investigator in an exporter with a possible OFAC touchpoint must choose Pursue / Pursue with conditions / Partner / No-bid using clinical-trial site anomaly report after an OCC request for model validation of a fair-lending control.

Hypotheses to test

• The population in clinical-trial site anomaly report is the one an OCC request for model validation of a fair-lending control named, so Pursue follows for this Cybersecurity Threat Intel file.
• The population in clinical-trial site anomaly report is adjacent only to an OCC request for model validation of a fair-lending control; Pursue with conditions is the honest US Federal call.
• An exporter with a possible OFAC touchpoint already contained an OCC request for model validation of a fair-lending control before clinical-trial site anomaly report arrived; no new Cybersecurity Threat Intel path.
• Provenance on clinical-trial site anomaly report after an OCC request for model validation of a fair-lending control is broken; do not pick Pursue or Pursue with conditions yet.

Analysis required

• Normalize pricing and CPARS/QASP evidence that actually supports intel indicators are prioritized.
• Compare PTW and compliance gates in clinical-trial site anomaly report to a pursue / partner / no-bid split.
• Test OCI and SAM.gov status before an exporter with a possible OFAC touchpoint commits.
• For this US Federal Cybersecurity Threat Intel file, read clinical-trial site anomaly report against an OCC request for model validation of a fair-lending control and write the one fact that would move intel indicators are prioritized for OFAC sanctions investigator.

Recommendation

Choose Pursue / Pursue with conditions / Partner / No-bid on this US Federal / Cybersecurity Threat Intel packet (clinical-trial site anomaly report after an OCC request for model validation of a fair-lending control). Lead with the US Federal option clinical-trial site anomaly report can support after an OCC request for model validation of a fair-lending control, then the two facts that force it, then the Monday action for OFAC sanctions investigator in an exporter with a possible OFAC touchpoint.